{"acquisitions":[],"changes":[],"country":"US","description":"Tavo Biotherapeutics develops therapies for ophthalmic neurodegeneration, with a focus on glaucoma and retinal diseases. It targets patients losing vision to glaucoma and the ophthalmologists treating them. Programs aim at neuroprotective and disease-modifying mechanisms in eye care.","domain":"tavobio.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":35.146025,"lng":-90.051764,"location":"MEMPHIS, Tennessee","multiples":[],"name":"OCULO THERAPY LLC","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":2081932,"connectionsAmong":[],"currency":"USD","date":"2024-01-01","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"tavobio-com-2024-01-01-grant","source":{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-08","status":"attributed","url":null},"status":"attributed","type":"grant","url":null}],"slug":"tavobio-com","sources":[{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-08","status":"attributed","url":null},{"fact":"existence","publisher":"tavobio.com","retrievedAt":"2026-05-08","status":"self-reported","url":"https://tavobio.com"},{"fact":"description","publisher":"tavobio.com","retrievedAt":"2026-05-08","status":"self-reported","url":"https://tavobio.com"}],"stage":null,"stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":["Google Analytics","Google Tag Manager","Framer Sites","MongoDB","Node.js","React 16.13.1"],"totalRaisedUsd":2081932,"traction":[],"updatedAt":"2026-05-08","valuations":[]}